On Friday, Pacific Biosciences of California Inc (NASDAQ: PACB) was 18.09% up from the session before settling in for the closing price of $1.88. A 52-week range for PACB has been $0.85 – $2.46.
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.55%. When this article was written, the company’s average yearly earnings per share was at -64.88%. With a float of $270.83 million, this company’s outstanding shares have now reached $301.85 million.
Pacific Biosciences of California Inc (PACB) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pacific Biosciences of California Inc stocks. The insider ownership of Pacific Biosciences of California Inc is 10.29%, while institutional ownership is 52.61%. The most recent insider transaction that took place on Aug 18 ’25, was worth 35,182. In this transaction an insider of this company sold 26,836 shares at a rate of $1.31, taking the stock ownership to the 1,920,035 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Officer proposed sale 26,836 for $1.31, making the entire transaction worth $35,174.
Pacific Biosciences of California Inc (PACB) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.2 earnings per share (EPS) during the time that was less than consensus figure (set at -0.17) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -64.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.32% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
You can see what Pacific Biosciences of California Inc (PACB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.18, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Looking closely at Pacific Biosciences of California Inc (NASDAQ: PACB), its last 5-days average volume was 10.1 million, which is a jump from its year-to-date volume of 9.31 million. As of the previous 9 days, the stock’s Stochastic %D was 74.00%.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 87.70%, which indicates a significant decrease from 97.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.65, while its 200-day Moving Average is $1.38. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $2.36. Second resistance stands at $2.50. The third major resistance level sits at $2.76. If the price goes on to break the first support level at $1.96, it is likely to go to the next support level at $1.69. Now, if the price goes above the second support level, the third support stands at $1.55.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
There are 301,907K outstanding shares of the company, which has a market capitalization of 670.23 million. As of now, sales total 154,010 K while income totals -309,850 K. Its latest quarter income was 38,440 K while its last quarter net income were -38,000 K.
